Total return falls 13 to 24% - Novavax slips 161% in total return and back to 2nd spot

Novavax slips this week, with its return dropping by 161%, resulting in Moderna leapfrogging back to first overall. BioNTech also gives back 84% from its total return.

GeoVax makes a major move back into the TOP TEN, with a gain of 79% on its total return.

The overall return of all COVID VACCINE STOCKS moves down 13% down to 244%.